Jason E. Flick

Array ( [id] => 687240 [patent_doc_number] => 07078515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => 'Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus' [patent_app_type] => utility [patent_app_number] => 10/451126 [patent_app_country] => US [patent_app_date] => 2001-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12087 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078515.pdf [firstpage_image] =>[orig_patent_app_number] => 10451126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7318901 [patent_doc_number] => 20040224910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Recombinant nematode nicotinic receptor and uses' [patent_app_type] => new [patent_app_number] => 10/010873 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5934 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224910.pdf [firstpage_image] =>[orig_patent_app_number] => 10010873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716407 [patent_doc_number] => 20030027755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Compositions and methods for the rescue of white matter' [patent_app_type] => new [patent_app_number] => 10/013812 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12912 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027755.pdf [firstpage_image] =>[orig_patent_app_number] => 10013812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 373120 [patent_doc_number] => 07473423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-06 [patent_title] => 'Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system' [patent_app_type] => utility [patent_app_number] => 10/010729 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 167 [patent_no_of_words] => 64090 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/473/07473423.pdf [firstpage_image] =>[orig_patent_app_number] => 10010729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 415369 [patent_doc_number] => 07279553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'PRO1083 polypeptides' [patent_app_type] => utility [patent_app_number] => 10/165067 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 252 [patent_figures_cnt] => 253 [patent_no_of_words] => 185980 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279553.pdf [firstpage_image] =>[orig_patent_app_number] => 10165067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730178 [patent_doc_number] => 20030186368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/164728 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 238 [patent_figures_cnt] => 238 [patent_no_of_words] => 188204 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186368.pdf [firstpage_image] =>[orig_patent_app_number] => 10164728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7348372 [patent_doc_number] => 20040248240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof' [patent_app_type] => new [patent_app_number] => 09/977579 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20673 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248240.pdf [firstpage_image] =>[orig_patent_app_number] => 09977579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083103 [patent_doc_number] => 20050048483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Novel secreted proteins and their uses' [patent_app_type] => utility [patent_app_number] => 10/363374 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26915 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048483.pdf [firstpage_image] =>[orig_patent_app_number] => 10363374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972244 [patent_doc_number] => 20050037954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Novel agents for ameliorating motor disorder' [patent_app_type] => utility [patent_app_number] => 10/472444 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5732 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037954.pdf [firstpage_image] =>[orig_patent_app_number] => 10472444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311085 [patent_doc_number] => 07528109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders' [patent_app_type] => utility [patent_app_number] => 09/880097 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10824 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528109.pdf [firstpage_image] =>[orig_patent_app_number] => 09880097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 798011 [patent_doc_number] => 07427598 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory' [patent_app_type] => utility [patent_app_number] => 10/296849 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20374 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427598.pdf [firstpage_image] =>[orig_patent_app_number] => 10296849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847703 [patent_doc_number] => 20030166870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Anti-CCR5 antibodies and methods of use therefor' [patent_app_type] => new [patent_app_number] => 09/870932 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 24262 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166870.pdf [firstpage_image] =>[orig_patent_app_number] => 09870932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033645 [patent_doc_number] => 20050032155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Mutation in the beta2 nicotinic acetycholine receptor subunit associated with nocturnal frontal lobe epilepsy' [patent_app_type] => utility [patent_app_number] => 10/275858 [patent_app_country] => US [patent_app_date] => 2001-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10884 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032155.pdf [firstpage_image] =>[orig_patent_app_number] => 10275858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 243032 [patent_doc_number] => 07588766 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-09-15 [patent_title] => 'Treatment of amyloidogenic disease' [patent_app_type] => utility [patent_app_number] => 09/723765 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 25 [patent_no_of_words] => 41000 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/588/07588766.pdf [firstpage_image] =>[orig_patent_app_number] => 09723765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256207 [patent_doc_number] => 07575880 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-08-18 [patent_title] => 'Method of screening an antibody for activity in clearing an amyloid deposit' [patent_app_type] => utility [patent_app_number] => 09/724288 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 25 [patent_no_of_words] => 40918 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/575/07575880.pdf [firstpage_image] =>[orig_patent_app_number] => 09724288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 277864 [patent_doc_number] => 07556938 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-07-07 [patent_title] => 'Nucleic acids encoding potassium channel interactors' [patent_app_type] => utility [patent_app_number] => 09/703094 [patent_app_country] => US [patent_app_date] => 2000-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 84 [patent_no_of_words] => 68720 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/556/07556938.pdf [firstpage_image] =>[orig_patent_app_number] => 09703094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 555926 [patent_doc_number] => 07157243 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-02 [patent_title] => 'DNA encoding mammalian T-type calcium channels' [patent_app_type] => utility [patent_app_number] => 09/611257 [patent_app_country] => US [patent_app_date] => 2000-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 24 [patent_no_of_words] => 8832 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157243.pdf [firstpage_image] =>[orig_patent_app_number] => 09611257 [rel_patent_id] =>[rel_patent_doc_number] =>)